|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.526 SEK | +17.41% |
|
+31.83% | +105.47% |
| 06:00pm | Global markets live: Microsoft, Roche, BMW, Nintendo, Nordson... |  |
| 06:41am | InDex Pharmaceuticals to Buy Flerie Invest Under Reverse Merger Plan | MT |
InDex Pharmaceuticals Holding AB (publ) reported earnings results for the full year ended December 31, 2022. For the full year, the company reported revenue was SEK 47.89 million compared to SEK 12.72 million a year ago. Net loss was SEK 100.33 million compared to SEK 103.04 million a year ago.
Basic loss per share from continuing operations was SEK 0.19 compared to SEK 0.21 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +105.47% | 22.32M | |
| +37.78% | 705B | |
| +32.82% | 583B | |
| -3.51% | 364B | |
| +19.94% | 332B | |
| +5.14% | 291B | |
| +16.64% | 238B | |
| -4.13% | 210B | |
| +10.63% | 209B | |
| +9.32% | 169B |
INDEX PHARMACEUTICALS HOLDING AB 
